Enoxaparin prophylaxis for deep vein thrombosis after laparoscopic cholecystectomy

Phase 3, open-label trial of enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Absence of deep vein thrombosis at 14 days and Absence of pulmonary embolism at 14 days. Started Jun 2021; status: completed.